BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21424291)

  • 1. [Tissue engineering of heart valves].
    Akhyari P; Minol P; Assmann A; Barth M; Kamiya H; Lichtenberg A
    Chirurg; 2011 Apr; 82(4):311-8. PubMed ID: 21424291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?
    Badria AF; Koutsoukos PG; Mavrilas D
    J Mater Sci Mater Med; 2020 Dec; 31(12):132. PubMed ID: 33278023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart valve and myocardial tissue engineering].
    Cebotari S; Tudorache I; Schilling T; Haverich A
    Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological heart valves.
    Ciubotaru A; Cebotari S; Tudorache I; Beckmann E; Hilfiker A; Haverich A
    Biomed Tech (Berl); 2013 Oct; 58(5):389-97. PubMed ID: 24101369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for development of decellularized heart valve scaffolds for tissue engineering.
    Snyder Y; Jana S
    Biomaterials; 2022 Sep; 288():121675. PubMed ID: 35953330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
    Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineering strategies for polymeric scaffold for tissue engineering an aortic heart valve: an update.
    Morsi YS
    Int J Artif Organs; 2014 Sep; 37(9):651-67. PubMed ID: 25262629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular tissue engineering: From basic science to clinical application.
    Fioretta ES; von Boehmer L; Motta SE; Lintas V; Hoerstrup SP; Emmert MY
    Exp Gerontol; 2019 Mar; 117():1-12. PubMed ID: 29604404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.
    Fioretta ES; Motta SE; Lintas V; Loerakker S; Parker KK; Baaijens FPT; Falk V; Hoerstrup SP; Emmert MY
    Nat Rev Cardiol; 2021 Feb; 18(2):92-116. PubMed ID: 32908285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds.
    Muylaert DE; Fledderus JO; Bouten CV; Dankers PY; Verhaar MC
    Heart; 2014 Dec; 100(23):1825-30. PubMed ID: 25053725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart valve engineering: decellularized allograft matrices in clinical practice.
    Neumann A; Cebotari S; Tudorache I; Haverich A; Sarikouch S
    Biomed Tech (Berl); 2013 Oct; 58(5):453-6. PubMed ID: 23729596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Challenges in Cardiovascular Tissue Engineering.
    Emmert MY; Fioretta ES; Hoerstrup SP
    J Cardiovasc Transl Res; 2017 Apr; 10(2):139-149. PubMed ID: 28281240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue engineering of heart valves: advances and current challenges.
    Mol A; Smits AI; Bouten CV; Baaijens FP
    Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineering of autologous heart valves: a focused update.
    Le Huu A; Shum-Tim D
    Future Cardiol; 2014 Jan; 10(1):93-104. PubMed ID: 24344666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current developments in the tissue engineering of autologous heart valves: moving towards clinical use.
    Apte SS; Paul A; Prakash S; Shum-Tim D
    Future Cardiol; 2011 Jan; 7(1):77-97. PubMed ID: 21174513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous implantation of the pulmonary and aortic valves: indications and limitations.
    Khambadkone S; Nordmeyer J; Bonhoeffer P
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):57-61. PubMed ID: 17255818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decellularization and characterization of camel pericardium as a new scaffold for tissue engineering and regenerative medicine.
    Jafari Sorkhdehi MM; Doostmohammadi A; Talebi A; Alizadeh A
    Asian Cardiovasc Thorac Ann; 2024 May; 32(4):194-199. PubMed ID: 38767039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-engineered heart valve scaffolds.
    Dohmen PM; Konertz W
    Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):362-7. PubMed ID: 20081743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials.
    Iop L; Gerosa G
    Biomed Res Int; 2015; 2015():432901. PubMed ID: 26495295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.